GenerateBiomedicines Launches Phase 3 Trials of GB-0895 for Severe Asthma GenerateBiomedicines embarks on pivotal Phase 3 trials for GB-0895, an advanced treatment for severe asthma, showcasing the potential of AI-driven drug design.

GenerateBiomedicines Launches Phase 3 Trials of GB-0895 for Severe Asthma #USA #Somerville #GenerateBiomedicines #GB-0895 #SOLAIRIA

🛠️ SOLAIRIA: Offline AI Assistant

SOLAIRIA is a customizable, offline alternative to ChatGPT, supporting GGUF models. It offers both GPU and CPU modes, ensuring compatibility across Windows and Linux systems.

#SOLAIRIA #OfflineAI #GGUF #PrivacyFirst